Clinical Trial

Safety and Effectiveness of the Vascular Closure Device for Femoral Artery Hemostasis in Patients of Femoral Artery Puncture

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 12, 2025 (before its estimated March 2, 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to verify the safety and effectiveness of the Vascular Closure Device manufactured by Shanghai Bomaian Medical Technology Co., Ltd. for femoral artery hemostasis in patients of femoral artery puncture.
Trial Details
NCT Number NCT07279220
Lead Sponsor Shanghai Bomaian Medical Technology Co., Ltd
Conditions Femoral Artery Puncture, Vascular Closure Device, Hemostasis
Enrollment 238 participants
Start Date 2025-12-29
Primary Completion 2026-03-02 (estimated)
Study Completion 2026-05-15 (estimated)
Updated on ClinicalTrials.gov 2025-12-12